Related Experiment Video
Updated: May 3, 2026

08:37
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
16.5K
Immune cell traits and causal relationships with cholecystitis: a mendelian randomization analysis
Ze-Fa Xiao1, Wei-Hao Chai2, Xiao-Long Shu1
1The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|October 2, 2024
Summary
This study used Mendelian randomization to identify causal links between immune cells and cholecystitis risk. It found 21 immune cell phenotypes causally related to gallbladder inflammation, paving the way for targeted treatments.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
Background:
- Cholecystitis (gallbladder inflammation) involves immune cells, but their specific causal roles are unclear.
- Understanding immune cell contributions is crucial for developing effective cholecystitis treatments.
Purpose of the Study:
- To investigate the causal relationships between 731 immune cell phenotypes and cholecystitis using Mendelian randomization (MR).
- To identify specific immune cell markers that influence cholecystitis risk for precision medicine.
Main Methods:
- Employed a two-sample Mendelian randomization (MR) analysis using genome-wide association studies (GWAS) data.
- Utilized single nucleotide polymorphisms (SNPs) as genetic instrumental variables for immune cell phenotypes and cholecystitis.
- Conducted sensitivity analyses and reverse MR to ensure result robustness and rule out reverse causality.
Main Results:
- Identified 21 out of 731 immune cell phenotypes with a significant causal relationship to cholecystitis (P < 0.05).
- Eight immune phenotypes showed a protective effect (OR < 1), while 13 increased cholecystitis risk (OR > 1).
- False discovery rate (FDR) analysis did not reveal significant causal links at FDR < 0.2.
Conclusions:
- Immune cell phenotypes play a significant causal role in the development and progression of cholecystitis.
- These findings support the development of novel biomarkers and targeted therapies for personalized cholecystitis treatment.
- The study provides a foundation for improving patient outcomes and mitigating the disease's impact.
Related Concept Videos
Autoimmune Disorders
2.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Inflammatory Bowel Disease III: Crohn's Disease
35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Cholecystitis
29
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
29

